| ||||||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Tooth decay (Lactobacillus GG) |
![]() |
Colic (Bifidobacterium lactis and Streptococcus thermophilus) Crohn’s disease(Saccharomyces boulardii) HIV support (Saccharomyces boulardii) Pancreatitis (acute) (Lactobacillus plantarum) |
![]() |
|
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
People using antibiotics, eating a poor diet, or suffering from diarrhoea are more likely to have depleted colonies of friendly bacteria.
The amount of probiotics necessary to replenish the intestine varies according to the extent of microbial depletion and the presence of harmful bacteria. One to two billion colony forming units (CFUs) per day of acidophilus is considered to be the minimum amount for the healthy maintenance of intestinal microflora. Some Saccharomyces boulardii research has used 500 mg taken four times per day.
There are at least nine case reports of severe, invasive (internal) fungal infections developing in people treated with the yeast organism Saccharomyces boulardii. All of these people were debilitated or had impaired immune function prior to receiving Saccharomyces boulardii.23 24 No such adverse reactions have been reported with other probiotic supplements or in people with normal immune systems.
Acidophilus and bifidobacteria may manufacture B vitamins, including niacin, folic acid, biotin, and vitamin B6.
Are there any drug
interactions?
Certain medicines may interact with probiotics. Refer to drug interactions for a list of those medicines.
1. Smirnov VV, Reznik SR, V’iunitskaia VA, et al. The current concepts of the mechanisms of the therapeutic-prophylactic action of probiotics from bacteria in the genus bacillus. Mikrobiolohichnyi Zhurnal 1993;55:92–112.
2. Mel’nikova VM, Gracheva NM, Belikov GP, et al. The chemoprophylaxis and chemotherapy of opportunistic infections. Antibiotiki i Khimioterapiia 1993;38:44–8.
3. De Simone C, Vesely R, Bianchi SB, et al. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993;9:23–8.
4. Veldman A. Probiotics. Tijdschrift voor Diergeneeskunde 1992;117:345–8.
5. Kawase K. Effects of nutrients on the intestinal microflora of infants. Jpn J Dairy Food Sci 1982;31:A241–3.
6. Rasic JL. The role of dairy foods containing bifido and acidophilus bacteria in nutrition and health. N Eur Dairy J 1983;4:80–8.
7. Barefoot SF, Klaenhammer TR. Detection and activity of Lactacin B, a Bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol 1983;45:1808–15.
8. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000;54:263–7.
9. Perdigon G, Alvarez S, Rachid M, et al. Immune system stimulation by probiotics. J Dairy Sci 1995;78:1597–606.
10. Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992;116:353–7.
11. Reid G, Millsap K, Bruce AW. Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet 1994;344:1229.
12. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents.JAMA 1996;275:870–6.
13. Scarpignato C, Rampal P. Prevention and treatment of traveler’s diarrhea: a clinical pharmacological approach. Chemotherapy 1995;41:48–81.
14. Bengmark S. Econutrition and health maintenance: A new concept to prevent inflammation, ulceration and sepsis. Clin Nutr 1996;15:1–10.
15. Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol 2000;95(1 Suppl):S5–7 [review].
16. Olah A, Belagyi T, Issekutz A, et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002;89:1103–7.
17. Golledge CL, Riley TV. "Natural" therapy for infectious diseases. Med J Aust 1996;164:94–5 [review].
18. Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 1997;23:517–23.
19. Loizeau E. Can antibiotic-associated diarrhea be prevented? Ann Gastroenterol Hepatol 1993;29:15–8.
20. McDonough FE, Hitchins AD, Wong NP, et al. Modification of sweet acidophilus milk to improve utilization by lactose-intolerant persons. Am J Clin Nutr 1987;45:570–4.
21. Williams CH, Witherly SA, Buddington, RK. Influence of Dietary Neosugar on Selected Bacterial Groups of the Human Faecal Microbiota. Microb Ecol Health Dis 1994;7:91–7.
22. Gibson GR. Dietary modulation of the human gut microflora using probiotics. Br J Nutr 1998;80(Suppl 2):S209–S12.
23. Bassetti S, Frei R, Zimmerli W. Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am J Med 1998;105:71–2.
24. Perapoch J, Planes AM, Querol A, et al. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with Ultra-Levura. Eur J Clin Microbiol Infect Dis 2000;19:468–70.
| |||||||